VALIANT LABORATORIES Financial Statement Analysis
|
||
|
The Revenues of VALIANT LABORATORIES have decreased by -26.74% YoY .
The Earnings Per Share (EPS) of VALIANT LABORATORIES has decreased by Negative YoY. |
||
| REVENUES |
| OPERATING MARGIN |
| PROFIT AFTER TAX |
| EPS |
| ROCE |
VALIANT LABORATORIES Last 5 Annual Financial Results
[BOM: 543998|NSE : VALIANTLAB]
| Consolidated | Mar2025 | Mar2024 | Mar2023 |
|---|---|---|---|
| Revenues | ₹133 Cr | ₹182 Cr | ₹334 Cr |
| Expenses | ₹138 Cr | ₹190 Cr | ₹299 Cr |
| Operating Profit (Excl OI) | ₹-4.69 Cr | ₹-8.41 Cr | ₹35 Cr |
| Other Income | ₹5.45 Cr | ₹9.68 Cr | ₹4.89 Cr |
| Interest | ₹0.18 Cr | ₹0.08 Cr | ₹0.25 Cr |
| Depreciation | ₹2.09 Cr | ₹1.97 Cr | ₹1.56 Cr |
| Profit Before Tax | ₹-1.51 Cr | ₹-0.77 Cr | ₹38 Cr |
| Profit After Tax | ₹-2.20 Cr | ₹0.32 Cr | ₹29 Cr |
| Consolidated Net Profit | ₹-2.20 Cr | ₹0.32 Cr | ₹29 Cr |
| Earnings Per Share (Rs) | ₹-0.51 | ₹0.07 | ₹8.91 |
| PAT Margin (%) | -1.65 | 0.18 | 8.68 |
| ROE(%) | -0.93 | 0.19 | 28.86 |
| ROCE(%) | -0.40 | -0.29 | 24.01 |
| Total Debt/Equity(x) | 0.52 | 0.32 | 0.59 |
Key Financials |
||
| Market Cap | : | ₹ 419.2 Cr |
| Revenue (TTM) | : | ₹ 186.0 Cr |
| Net Profit(TTM) | : | ₹ 5.1 Cr |
| EPS (TTM) | : | ₹ 0.9 |
| P/E (TTM) | : | 82.7 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| VALIANT LABORATORIES | -2.3% | -7.9% | -27.2% |
| SUN PHARMACEUTICAL INDUSTRIES | 1.2% | 5.3% | 0.9% |
| DIVIS LABORATORIES | -0.7% | -2.1% | 12.4% |
| CIPLA | -0.2% | -6.7% | 1.8% |
| TORRENT PHARMACEUTICALS | -3.2% | 4.1% | 20.2% |
| DR REDDYS LABORATORIES | 0.2% | -2.7% | 2% |
| MANKIND PHARMA | -1.3% | -8.8% | -14.7% |
| ZYDUS LIFESCIENCES | -1.7% | -7.4% | -2.9% |
| LUPIN | -1.2% | 4.4% | 0.6% |
VALIANT LABORATORIES Revenues
[BOM: 543998|NSE : VALIANTLAB]
| Y-o-Y | -26.74 % |
| 5 Yr CAGR | -36.80 % |
| Years | Revenues | % Change | |
|---|---|---|---|
| Mar2025 | ₹133 Cr | -26.74 | |
| Mar2024 | ₹182 Cr | -45.48 | |
| Mar2023 | ₹334 Cr | - | |
VALIANT LABORATORIES Operating Profit
[BOM: 543998|NSE : VALIANTLAB]
| Y-o-Y | Negative |
| 5 Yr CAGR | Negative |
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹-4.69 Cr | Negative | |
| Mar2024 | ₹-8.41 Cr | Negative | |
| Mar2023 | ₹35 Cr | - | |
| Operating Margins | |
|---|---|
| Y-o-Y | Negative |
| 5 Yr CAGR | Negative |
| Years | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2025 | -3.52% | Negative | |
| Mar2024 | -4.62% | Negative | |
| Mar2023 | 10.5% | - | |
VALIANT LABORATORIES Profit After Tax
[BOM: 543998|NSE : VALIANTLAB]
| Y-o-Y | Negative |
| 5 Yr CAGR | Negative |
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2025 | ₹-2.20 Cr | Negative | |
| Mar2024 | ₹0.32 Cr | -98.90 | |
| Mar2023 | ₹29 Cr | - | |
| PAT Margins | |
|---|---|
| Y-o-Y | Negative |
| 5 Yr CAGR | Negative |
| Years | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2025 | -1.65 % | Negative | |
| Mar2024 | 0.18 % | -97.93 | |
| Mar2023 | 8.68 % | - | |
VALIANT LABORATORIES Earnings Per Share (EPS)
[BOM: 543998|NSE : VALIANTLAB]
| Y-o-Y | Negative |
| 5 Yr CAGR | Negative |
| Years | EPS | % Change | |
|---|---|---|---|
| Mar2025 | ₹-0.51 | Negative | |
| Mar2024 | ₹0.07 | -99.21 | |
| Mar2023 | ₹8.91 | - | |
VALIANT LABORATORIES Return on Capital Employed (ROCE)
[BOM: 543998|NSE : VALIANTLAB]
| Y-o-Y | Negative |
| 5 Yr CAGR | Negative |
| Years | ROCE | % Change | |
|---|---|---|---|
| Mar2025 | -0.4% | Negative | |
| Mar2024 | -0.29% | Negative | |
| Mar2023 | 24.01% | - | |
VALIANT LABORATORIES Share Price vs Sensex
| Current Share Price | : | ₹77.2 |
| Current MarketCap | : | ₹ 419.2 Cr |
| Updated EOD on | : | Nov 20,2025 |
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| VALIANT LABORATORIES | -2.3% |
-7.9% |
-27.2% |
| SENSEX | 1.4% |
2% |
10.2% |
VALIANT LABORATORIES related INDICES
You may also like the below Video Courses
FAQ about VALIANT LABORATORIES Financials
How the annual revenues of VALIANT LABORATORIES have changed ?
The Revenues of VALIANT LABORATORIES have decreased by -26.74% YoY .
How the Earnings per Share (EPS) of VALIANT LABORATORIES have changed?
The Earnings Per Share (EPS) of VALIANT LABORATORIES has decreased by Negative YoY .
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs CIPLA LTD
TORRENT PHARMACEUTICALS LTD vs DR REDDYS LABORATORIES LTD vs